Advertisement
The Body: The Complete HIV/AIDS Resource Follow Us Follow Us on Facebook Follow Us on Twitter Download Our App
Professionals >> Visit The Body PROThe Body en Espanol

10 HIV/AIDS Stories That Defined 2011 in the US

December 1, 2011

 4/11 

The PrEP Debate

The PrEP Debate

Taking a daily pill to reduce HIV risk -- better known as pre-exposure prophylaxis, or PrEP -- remains one of the most exciting biomedical prevention strategies on the horizon. Daily use of some antiretrovirals has shown up to 73% efficacy in preventing HIV transmission among men who have sex with men (MSM). San Francisco will soon become the first city in the nation to offer PrEP to MSM.

PrEP's potential efficacy among women has been less clear, but this year we finally saw promising study results for heterosexual couples.

Still, PrEP is a polarizing topic. Depending upon whom you ask, it's often described as either a "magic bullet" or an unrealistic, "boutique" intervention. And questions abound, such as: Who will pay for it? And what are the health consequences of placing HIV-negative people on HIV medications they don't really need?




Rod McCullom has written and produced for ABC News and NBC, and has reported for Ebony, The Advocate, Colorlines, the Black AIDS Institute and others. Rod blogs on politics, pop culture and black gay news at rod20.com.


Copyright © 2011 The HealthCentral Network, Inc. All rights reserved.


This article was provided by TheBody.com.
 
See Also
Top 10 HIV/AIDS-Related Clinical Developments of 2011
What's the Buzz? The Top 10 Stories on TheBody.com in 2011
Read More Articles From TheBody.com's 2011 HIV/AIDS Year in Review

 

Add Your Comment:
(Please note: Your name and comment will be public, and may even show up in
Internet search results. Be careful when providing personal information! Before
adding your comment, please read TheBody.com's Comment Policy.)

Your Name:


Your Location:

(ex: San Francisco, CA)

Your Comment:

Characters remaining:

Advertisement